C4
Insider buying
Catalyst4, Inc. bought $50.1M of MapLight Therapeutics, Inc. (MPLT) stock
Catalyst4, Inc., 10% owner of MapLight Therapeutics, Inc. (MPLT), bought 4,400,000 shares of MPLT stock worth $50.1M, per an SEC Form 4 filed Aug 18, 2026.
It was an open-market purchase.
The trade happened on Aug 14, 2026, 4 days before it was made public.
MPLT has moved -7.2% since the trade date, from $11.75 to $10.90 (Sep 21, 2026 close).
- Traded
- Aug 14, 2026
- Disclosed
- Aug 18, 2026
- Filing delay
- 4 days
- Price since
- -7.2%
- Role
- 10% owner
- Source
- SEC Form 4
More MPLT insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.